Our history and future
2011
Founded
By researchers and dermatologists
2013
Clinically proven
In separate scientific studies
2014
Received CE Mark
First skin cancer app with CE mark
2020
1.2+ million
SkinVision users worldwide
Meet the team
Sales & Business Development
Erik de Heus
CEO
What we know is that skin cancer is the most common cancer in Western countries. And the amount of patients is rapidly growing. We embrace the idea that technology can take away the barriers that stand in the way of early detection of skin cancer, and get you to a doctor at the right time.
Your skin health is important to us. We invite you to join the SkinHealth program and make your skin health part of your everyday routine.
Regulatory & Compliance
Finance & HR
Customer Success & Medical
Development
Machine Learning
Marketing
Our Scientific Board
Prof. Thomas Ruzicka
Head of the Clinic for Dermatology at the Ludwig Maximilian University in Munich, Germany
Daniel Mark Siegel
CPCD Clinical Professor of Dermatology, SUNY Downstate Former President, American Academy of Dermatology
Prof. Dedee Murrell
Head of the Department of Dermatology at St George Hospital, University of New South Wales
Marlies Wakkee
Dermatologist and associate professor at the Erasmus MC Cancer Institute in Rotterdam, the Netherlands
Vera Heydendael
Tamar Nijsten
Daniel Mark Siegel
Mihaela Bloju
Cristina Beiu
Mihaela Radu
Alexandra Popa
Martijn Meijs
Irina Cudritchi
Marlies Wakkee
Prof. Dedee Murrell
Prof. Thomas Ruzicka
TECHNOLOGY
This is what we promise
Regulated & CE Marked
We are a regulated medical device with European CE marking. We are ISO certified for medical device and information security management.
Privacy
We provide a secure analysis, and a personal profile and archive. Read our privacy policy to learn more.
Accuracy
Proven accuracy that been clinically tested through three studies in Germany and The Netherlands. Read more on our research page.
